Piramal Enterprises | PEL | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
13,202
19,638
24,775
8,112
44,244
Cash flow Operating Act...
Cash flow Operating Activities
-100,393-159,666-115,97575,16336,645
Investments in PPE
Investments in PPE
21,864-8,188-6,914-4,707-5,952
Cash flow Investing Act...
Net cash used for Investment Activities
-24,202-17,677-8,26574,687-27,723
Dividend Paid
Dividend Paid
354,3284,4826,6803,158
Cash flow Financing Act...
Net cash provided by Financing Activities
135,705186,503107,525-130,18620,716
Cash at beginning of period
Cash at beginning of period
2,26613,64223,0066,23226,116
Cash at end of period
Cash at end of period
13,64223,0066,41326,11655,817
Free Cash Flow
Free Cash Flow
-78,529
-167,854
-122,888
70,457
30,694